Amrize (NYSE:AMRZ) CTO Roald Brouwer Purchases 1,500 Shares

Key Points

• Amrize CTO Roald Brouwer purchased 1,500 shares at an average price of $46.36, investing $69,540 and increasing his direct holdings by 7.5% to 21,490 shares.
• Amrize reported quarterly EPS of $0.88, missing the $0.92 analyst consensus, while revenue reached $3.50 billion. The stock traded near $46.65, close to its 52-week low of $46.03.
• The company declared a quarterly dividend of $0.11 per share, payable August 26 to shareholders of record August 19. Analysts maintain a “Moderate Buy” consensus with an average price target of $60.57.

Amrize Ltd (NYSE:AMRZ - Get Free Report) CTO Roald Brouwer bought 1,500 shares of the business's stock in a transaction that occurred on Tuesday, August 11th. The shares were bought at an average cost of $46.36 per share, with a total value of $69,540.00. Following the completion of the purchase, the chief technology officer directly owned 21,490 shares of the company's stock, valued at $996,276.40. This represents a 7.50% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.

Roald Brouwer also recently made the following trade(s):

• On Thursday, May 21st, Roald Brouwer purchased 1,500 shares of Amrize stock. The stock was bought at an average price of $49.84 per share, for a total transaction of $74,760.00.

Amrize Price Performance

Shares of Amrize stock traded up $0.28 during trading on Thursday, reaching $46.65. 1,261,074 shares of the stock traded hands, compared to its average volume of 3,206,131. The company has a market capitalization of $25.80 billion, a price-to-earnings ratio of 21.50, a P/E/G ratio of 1.02 and a beta of 0.11. The business has a fifty day simple moving average of $51.50 and a two-hundred day simple moving average of $54.58. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. Amrize Ltd has a 52-week low of $46.03 and a 52-week high of $65.94.

Amrize (NYSE:AMRZ - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.17%. The firm had revenue of $3.50 billion for the quarter. Sell-side analysts expect that Amrize Ltd will post 2.72 EPS for the current year.

Amrize Dividend Announcement

The company also recently disclosed a dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 19th will be issued a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, August 18th. Amrize's dividend payout ratio is 20.28%.

Institutional Trading of Amrize

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Norges Bank purchased a new position in shares of Amrize during the 4th quarter worth about $929,333,000. Harris Associates L P purchased a new position in Amrize during the 4th quarter valued at $615,406,000. Wellington Management Group LLP grew its position in Amrize by 48.8% in the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock valued at $561,018,000 after acquiring an additional 3,809,133 shares during the last quarter. Marshall Wace LLP grew its position in Amrize by 865.4% in the 3rd quarter. Marshall Wace LLP now owns 2,889,660 shares of the company's stock valued at $139,436,000 after acquiring an additional 2,590,336 shares during the last quarter. Finally, Barclays PLC increased its stake in Amrize by 95.4% in the fourth quarter. Barclays PLC now owns 4,614,593 shares of the company's stock worth $249,557,000 after purchasing an additional 2,253,431 shares during the period.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Oppenheimer cut their target price on shares of Amrize from $68.00 to $65.00 and set an "outperform" rating for the company in a report on Tuesday, July 21st. Weiss Ratings lowered shares of Amrize from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Friday, July 31st. Citigroup dropped their price objective on shares of Amrize from $66.00 to $58.00 and set a "buy" rating for the company in a research note on Tuesday. Vertical Research upgraded shares of Amrize from a "hold" rating to a "buy" rating and set a $70.00 target price on the stock in a research report on Friday, May 1st. Finally, Wells Fargo & Company decreased their target price on shares of Amrize from $65.00 to $58.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $60.57.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source